This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Alberta directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $20,000
Precision health IDEAS (Inclusion/Diversity/Equity/Accessibility/Sustainability) for NeuroHIV: disrupted immunometabolism in the brain
CIHR · 2024 · Co-investigator
- $2,500,000
Canadian HIV-Ageing Multidisciplinary Programmatic Strategy (CHAMPS) in NeuroHIV
CIHR · 2018 · Co-investigator
- $25,000
Canadian NeuroAIDS Research Team (CNART): interactions with aging and co-infections
CIHR · 2017 · Co-investigator
Precision health IDEAS (Inclusion/Diversity/Equity/Accessibility/Sustainability) for NeuroHIV: disrupted immunometabolism in the brain
Principal investigators: Power, Christopher; Lang, Raynell
Keywords: Animal Models; Biomarkers; Cell Cultures; Genomics; Hiv; Nervous System; Neuropsychiatric Disorders; Precision Health; Proteomcs; Therapeutics
Canadian HIV-Ageing Multidisciplinary Programmatic Strategy (CHAMPS) in NeuroHIV
Principal investigators: Power, Christopher; Fujiwara, Esther
Keywords: Ageing; Hiv; Inflammation; Micrornas; Myeloid Cells; Neurocognitive Impairments; Neuropathic Pain; Peroxisomes; Proteases; Sex And Gender
Canadian NeuroAIDS Research Team (CNART): interactions with aging and co-infections
Principal investigators: Power, Christopher; Fujiwara, Esther
Keywords: Aging; Biomarker; Ethnic Diversity; Hepatitis C Virus; Hiv/Aids; Neuroaids; Neurocognitive Impairment; Neuropathic Pain; Sex And Gender Diversity; Syphillis
Towards a transformative understanding of HAND
Principal investigators: Power, Christopher; Broadhurst, David I; Cohen, Eric A; Hobman, Tom C; Seidah, Nabil G
Keywords: Biochemistry; Comorbidity; Epidemiology; Hiv/Aids; Immunology; Micrornas; Neurological Disease; Neurology; Proprotein Convertase
Towards a transformative understanding of HAND
Principal investigators: Power, Christopher
Keywords: Biomarker; Cart; Clinical Cohort; Cohort Survival; Deep Sequencing; Hand; Hiv/Aids; Innate Immunity; Microrna; Neurocognitive Impairment
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.